ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

HCFA Draft Document Dampens Jubilation Over Clinton Plan To Pay Patient Care Costs.

June 16, 2000

Frederick RFP Held Up; NCI Probably Will Reject Any Further Delay

October 15, 1976

Cancer Policy: EMFs “Possible” Carcinogen, Panel Says; Plans Public Hearings

August 7, 1998

Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk

January 31, 2014

NIH Director’s Office Funds $106 Million In Cancer Grants With Stimulus Dollars

September 18, 2009

Van Nevel New NCI information Chief: Karel Leaves For Johnson Foundation

August 30, 1974